2021
DOI: 10.1016/j.phoj.2022.04.008
|View full text |Cite
|
Sign up to set email alerts
|

Impact of flow cytometry based minimal residual disease in predicting clinical outcomes in children with BFM-95 moderate risk acute lymphoblastic leukemia

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles